Fractyl Health (NASDAQ:GUTS) CEO Acquires $18,250.00 in Stock

Fractyl Health, Inc. (NASDAQ:GUTS) CEO Harith Rajagopalan purchased 25,000 shares of Fractyl Health stock in a transaction dated Wednesday, June 10th. The shares were purchased at an average price of $0.73 per share, with a total value of $18,250.00. Following the completion of the acquisition, the chief executive officer owned 540,557 shares in the company, valued at $394,606.61. The trade was a 4.85% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Fractyl Health Stock Down 1.1%

Shares of Fractyl Health stock traded down $0.01 during trading on Thursday, hitting $0.72. 604,328 shares of the stock traded hands, compared to its average volume of 3,974,317. The stock has a market cap of $114.85 million, a P/E ratio of -0.56 and a beta of 2.34. The company has a debt-to-equity ratio of 1.41, a quick ratio of 4.28 and a current ratio of 4.28. Fractyl Health, Inc. has a twelve month low of $0.38 and a twelve month high of $2.45. The company has a fifty day moving average price of $0.68 and a two-hundred day moving average price of $1.08.

Fractyl Health (NASDAQ:GUTS) last posted its earnings results on Tuesday, May 12th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.23. Equities research analysts predict that Fractyl Health, Inc. will post -0.6 EPS for the current fiscal year.

Institutional Trading of Fractyl Health

Several large investors have recently made changes to their positions in the business. Pale Fire Capital SE lifted its stake in Fractyl Health by 84.5% in the first quarter. Pale Fire Capital SE now owns 5,921,045 shares of the company’s stock valued at $2,711,000 after buying an additional 2,711,103 shares during the period. Accredited Investors Inc. acquired a new position in Fractyl Health in the first quarter valued at about $46,000. Virtu Financial LLC acquired a new position in Fractyl Health in the fourth quarter valued at about $153,000. Susquehanna Portfolio Strategies LLC acquired a new position in Fractyl Health in the fourth quarter valued at about $108,000. Finally, Quadrature Capital Ltd lifted its stake in Fractyl Health by 2,047.1% in the fourth quarter. Quadrature Capital Ltd now owns 290,714 shares of the company’s stock valued at $640,000 after buying an additional 277,174 shares during the period.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Wall Street Zen upgraded Fractyl Health from a “strong sell” rating to a “hold” rating in a research report on Saturday, May 16th. Weiss Ratings restated a “sell (e+)” rating on shares of Fractyl Health in a research report on Tuesday, May 12th. HC Wainwright restated a “buy” rating and set a $8.00 price objective on shares of Fractyl Health in a research report on Thursday, June 4th. Finally, Canaccord Genuity Group restated a “buy” rating and set a $8.00 price objective on shares of Fractyl Health in a research report on Thursday, March 26th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $5.40.

Fractyl Health Company Profile

Fractyl Health, Inc is a clinical-stage medical technology company focused on the development and commercialization of minimally invasive, endoscopic therapies for metabolic diseases. Headquartered in Lexington, Massachusetts, Fractyl is advancing treatments that target the underlying physiology of conditions such as type 2 diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) by modifying the duodenal mucosa to improve metabolic control.

The company’s lead product, Revita® Duodenal Mucosal Resurfacing (Revita DMR), employs a catheter-based hydrothermal ablation technique to remodel the lining of the upper small intestine.